Israel Englander Galmed Pharmaceuticals Ltd. Transaction History

Millennium Management LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.4 - $0.9 $7,035 - $15,830	-17,589 Reduced 11.79%	131,628 $56,000
Q4 2022 Feb 14, 2023	BUY	$0.29 - $84.61 $29,681 - $8.66 Million	102,351 Added 218.39%	149,217 $75,000
Q3 2022 Nov 14, 2022	SELL	$0.35 - $59.37 $1,358 - $230,474	-3,882 Reduced 7.65%	46,866 $15,000
Q2 2022 Aug 15, 2022	BUY	$0.44 - $1.77 $17,601 - $70,805	40,003 Added 372.29%	50,748 $35,000
Q1 2022 May 16, 2022	SELL	$1.23 - $2.07 $52,267 - $87,962	-42,494 Reduced 79.82%	10,745 $17,000
Q4 2021 Feb 14, 2022	BUY	$1.75 - $3.03 $70,355 - $121,815	40,203 Added 308.4%	53,239 $97,000
Q3 2021 Nov 15, 2021	BUY	$2.41 - $3.33 $31,416 - $43,409	13,036 New	13,036 $36,000
Q2 2020 Aug 14, 2020	SELL	$3.22 - $6.08 $76,178 - $143,840	-23,658 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$3.3 - $6.84 $28,571 - $59,220	8,658 Added 57.72%	23,658 $82,000
Q4 2019 Feb 14, 2020	BUY	$3.61 - $6.75 $54,150 - $101,250	15,000 New	15,000 $87,000
Q1 2019 May 14, 2019	SELL	$7.27 - $9.07 $150,532 - $187,803	-20,706 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.59 - $14.47 $2.04 Million - $4.48 Million	-309,397 Reduced 93.73%	20,706 $141,000
Q3 2018 Nov 14, 2018	BUY	$10.55 - $15.28 $155,580 - $225,334	14,747 Added 4.68%	330,103 $4.48 Million
Q2 2018 Aug 14, 2018	BUY	$5.04 - $17.96 $1.5 Million - $5.36 Million	298,476 Added 1768.22%	315,356 $3.75 Million
Q1 2018 May 15, 2018	BUY	$5.12 - $11.77 $86,425 - $198,677	16,880 New	16,880 $94,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $153M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.